Assignee

AMARIN PHARMACEUTICALS IE LTD

IE·124 granted patents·113 pending applications·3,504 citations·filing 2012–2025

Technology mixA61K237 A61P178 G01N37 G16Z17 C07C13 C12P12

Top patents by PatentIndex Score

237 records

0199US11285127B2Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapyAMARIN PHARMACEUTICALS IE LTD·Filed 2020·Granted Mar 29, 2022·8 cites·17 claims
0299US11213504B2Stable pharmaceutical composition and methods of using sameAMARIN PHARMACEUTICALS IE LTD·Filed 2020·Granted Jan 4, 2022·16 cites·11 claims
0399US11179362B2Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapyAMARIN PHARMACEUTICALS IE LTD·Filed 2020·Granted Nov 23, 2021·15 cites·20 claims
0499US11154526B2Methods of treating mixed dyslipidemiaAMARIN PHARMACEUTICALS IE LTD·Filed 2020·Granted Oct 26, 2021·18 cites·6 claims
0599US10973797B2Methods of reducing apolipoprotein c-IIIAMARIN PHARMACEUTICALS IE LTD·Filed 2020·Granted Apr 13, 2021·9 cites·20 claims
0699US10842766B2Stable pharmaceutical composition and methods of using sameAMARIN PHARMACEUTICALS IE LTD·Filed 2019·Granted Nov 24, 2020·11 cites·5 claims
0799US10792267B2Methods of treating mixed dyslipidemiaAMARIN PHARMACEUTICALS IE LTD·Filed 2019·Granted Oct 6, 2020·11 cites·13 claims
0899US10576054B1Methods of reducing the risk of a cardiovascular event in a subject at risk for cardiovascular diseaseAMARIN PHARMACEUTICALS IE LTD·Filed 2019·Granted Mar 3, 2020·45 cites·9 claims
0999US10568861B1Methods of reducing the risk of a cardiovascular event in a subject at risk for cardiovascular diseaseAMARIN PHARMACEUTICALS IE LTD·Filed 2019·Granted Feb 25, 2020·48 cites·7 claims
1099US10555925B1Methods of reducing the risk of a cardiovascular event in a subject at risk for cardiovascular diseaseAMARIN PHARMACEUTICALS IE LTD·Filed 2019·Granted Feb 11, 2020·48 cites·6 claims
1199US10278935B2Methods of reducing the risk of a cardiovascular event in a subject on statin therapyAMARIN PHARMACEUTICALS IE LTD·Filed 2018·Granted May 7, 2019·55 cites·30 claims
1299US10220013B2Methods of treating mixed dyslipidemiaAMARIN PHARMACEUTICALS IE LTD·Filed 2016·Granted Mar 5, 2019·53 cites·20 claims
1399US10166209B2Methods of reducing apolipoprotein C-IIIAMARIN PHARMACEUTICALS IE LTD·Filed 2015·Granted Jan 1, 2019·64 cites·7 claims
1499US9918954B2Methods of reducing the risk of a cardiovascular event in a subject on statin therapyAMARIN PHARMACEUTICALS IE LTD·Filed 2017·Granted Mar 20, 2018·63 cites·18 claims
1599US9855237B2Methods of treating mixed dyslipidemiaAMARIN PHARMACEUTICALS IE LTD·Filed 2015·Granted Jan 2, 2018·78 cites·3 claims
1699US9693984B2Methods of reducing the risk of a cardiovascular event in a subject on statin therapyAMARIN PHARMACEUTICALS IE LTD·Filed 2017·Granted Jul 4, 2017·81 cites·26 claims
1799US9693986B2Methods of reducing the risk of a cardiovascular event in a subject on statin therapyAMARIN PHARMACEUTICALS IE LTD·Filed 2017·Granted Jul 4, 2017·80 cites·30 claims
1899US9693985B2Methods of reducing the risk of a cardiovascular event in a subject on statin therapyAMARIN PHARMACEUTICALS IE LTD·Filed 2017·Granted Jul 4, 2017·80 cites·26 claims
1999US9623001B2Methods of reducing the risk of a cardiovascular event in a subject on statin therapyAMARIN PHARMACEUTICALS IE LTD·Filed 2016·Granted Apr 18, 2017·86 cites·17 claims
2099US9610272B2Methods of reducing the risk of a cardiovascular event in a subject on statin therapyAMARIN PHARMACEUTICALS IE LTD·Filed 2016·Granted Apr 4, 2017·147 cites·14 claims
2199US9603826B2Methods of reducing the risk of a cardiovascular event in a subject on statin therapyAMARIN PHARMACEUTICALS IE LTD·Filed 2013·Granted Mar 28, 2017·85 cites·13 claims
2299US9138415B2Stable pharmaceutical composition and methods of using sameAMARIN PHARMACEUTICALS IE LTD·Filed 2013·Granted Sep 22, 2015·63 cites·17 claims
2399US8709475B2Stable pharmaceutical composition and methods of using sameAMARIN PHARMACEUTICALS IE LTD·Filed 2013·Granted Apr 29, 2014·101 cites·12 claims
2499US8703185B2Stable pharmaceutical composition and methods of using sameAMARIN PHARMACEUTICALS IE LTD·Filed 2013·Granted Apr 22, 2014·102 cites·12 claims
2599US8691871B2Methods of treating mixed dyslipidemiaAMARIN PHARMACEUTICALS IE LTD·Filed 2013·Granted Apr 8, 2014·116 cites·14 claims
2699US8680144B2Methods of treating mixed dyslipidemiaAMARIN PHARMACEUTICALS IE LTD·Filed 2013·Granted Mar 25, 2014·102 cites·14 claims
2799US8669245B2Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapyAMARIN PHARMACEUTICALS IE LTD·Filed 2013·Granted Mar 11, 2014·105 cites·13 claims
2899US8642077B2Stable pharmaceutical composition and methods of using sameAMARIN PHARMACEUTICALS IE LTD·Filed 2013·Granted Feb 4, 2014·106 cites·19 claims
2999US8623406B2Stable pharmaceutical composition and methods of using sameAMARIN PHARMACEUTICALS IE LTD·Filed 2013·Granted Jan 7, 2014·109 cites·10 claims
3099US8617593B2Stable pharmaceutical composition and methods of using sameAMARIN PHARMACEUTICALS IE LTD·Filed 2013·Granted Dec 31, 2013·112 cites·20 claims
3199US8617594B2Stable pharmaceutical composition and methods of using sameAMARIN PHARMACEUTICALS IE LTD·Filed 2013·Granted Dec 31, 2013·113 cites·26 claims
3299US8551521B2Stable pharmaceutical composition and methods of using sameAMARIN PHARMACEUTICALS IE LTD·Filed 2013·Granted Oct 8, 2013·108 cites·8 claims
3399US8546372B2Methods of treating hypertriglyceridemiaAMARIN PHARMACEUTICALS IE LTD·Filed 2013·Granted Oct 1, 2013·105 cites·25 claims
3499US8524698B2Methods of treating hypertriglyceridemiaAMARIN PHARMACEUTICALS IE LTD·Filed 2013·Granted Sep 3, 2013·105 cites·8 claims
3599US8518929B2Methods of treating hypertriglyceridemiaAMARIN PHARMACEUTICALS IE LTD·Filed 2013·Granted Aug 27, 2013·104 cites·9 claims
3699US8431560B1Methods of treating hypertriglyceridemiaAMARIN PHARMACEUTICALS IE LTD·Filed 2012·Granted Apr 30, 2013·104 cites·20 claims
3799US8377920B2Methods of treating hypertriglyceridemiaAMARIN PHARMACEUTICALS IE LTD·Filed 2012·Granted Feb 19, 2013·126 cites·10 claims
3899US8367652B2Methods of treating hypertriglyceridemiaAMARIN PHARMACEUTICALS IE LTD·Filed 2012·Granted Feb 5, 2013·128 cites·18 claims
3999US8357677B1Methods of treating hypertriglyceridemiaAMARIN PHARMACEUTICALS IE LTD·Filed 2012·Granted Jan 22, 2013·128 cites·9 claims
4098US11717504B2Methods of reducing the risk of cardiovascular events in a subjectAMARIN PHARMACEUTICALS IE LTD·Filed 2020·Granted Aug 8, 2023·6 cites·20 claims
4198US11185525B2Methods of reducing apolipoprotein C-IIIAMARIN PHARMACEUTICALS IE LTD·Filed 2020·Granted Nov 30, 2021·9 cites·24 claims
4298US11116743B2Methods of reducing the risk of cardiovascular events in a subjectAMARIN PHARMACEUTICALS IE LTD·Filed 2021·Granted Sep 14, 2021·5 cites·12 claims
4398US11103477B2Stable pharmaceutical composition and methods of using sameAMARIN PHARMACEUTICALS IE LTD·Filed 2020·Granted Aug 31, 2021·3 cites·7 claims
4498US10987331B2Methods of treating mixed dyslipidemiaAMARIN PHARMACEUTICALS IE LTD·Filed 2019·Granted Apr 27, 2021·7 cites·4 claims
4598US10881632B2Stable pharmaceutical composition and methods of using sameAMARIN PHARMACEUTICALS IE LTD·Filed 2020·Granted Jan 5, 2021·5 cites·9 claims
4698US10842768B2Compositions and methods for lowering triglyceridesAMARIN PHARMACEUTICALS IE LTD·Filed 2019·Granted Nov 24, 2020·6 cites·9 claims
4798US10786478B2Methods of reducing the risk of cardiovascular events in a subjectAMARIN PHARMACEUTICALS IE LTD·Filed 2020·Granted Sep 29, 2020·5 cites·19 claims
4898US10722485B2Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapyAMARIN PHARMACEUTICALS IE LTD·Filed 2019·Granted Jul 28, 2020·12 cites·18 claims
4998US10292959B2Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapyAMARIN PHARMACEUTICALS IE LTD·Filed 2017·Granted May 21, 2019·18 cites·16 claims
5098US10265290B2Methods of reducing apolipoprotein C-IIIAMARIN PHARMACEUTICALS IE LTD·Filed 2014·Granted Apr 23, 2019·64 cites·8 claims

Showing the top 50 of 237 patent records by PatentIndex Score.

Join the waitlist — get patent alerts

Get an alert when AMARIN PHARMACEUTICALS IE LTD files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →